Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Desmopressin for Nocturia
NCT01552343Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Mar 2012
- Primary completion
- May 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desmopressin in nocturia, sponsored by Ferring Pharmaceuticals. Started Mar 2012; status: completed.
02
Drugs
desmopressin
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT01552343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01552343.